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SUMMARY
Two frequently used restriction-enzyme polymorphisms (RFLPs) of
coagulant F.IX, TaqI and XmnI, have been examined in five ethnic
groups: white Americans, black Americans, East Indians, Chinese,
and Malays. There is a distinct "cdine" in the frequencies of both
polymorphisms, from white Americans to Malays. The rarer type 2
alleles of both polymorphisms, in which middle recognition sites are
present-and which in our sample reach their highest frequencies in
white Americans-are marginally higher in four groups of Europeans
previously reported by others. The frequencies of the rarer alleles are
significantly higher in Europeans than in black Americans and East
Indians, and these alleles are essentially absent in Chinese and
Malays. The frequency of heterozygosity diminishes in the same or-
der, being zero in Malays for both polymorphisms. The polymor-
phisms are in strong linkage disequilibrium, and in all groups the type
1 allele for TaqI is disproportionately accompanied by the type 1 allele
for XmnI. The paucity of type 2 alleles and the low rate of heterozy-
gosity in four non-European groups suggest that the polymorphisms
will be of little diagnostic value south of Gibraltar and east of Suez.
This prediction is confirmed by the observed haplotype frequencies in
the black American and the Oriental groups.
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INTRODUCTION
F.IX is a glycoprotein involved in the blood-coagulation cascade whose gene
on the X chromosome has been isolated and characterized several times in
recent years (Choo et al. 1982; Kurachi and Davie 1982; Jaye et al. 1983; Anson
et al. 1984; Jagadeeswaran et al. 1984; McGraw et al. 1985; Yoshitake et al.
1985). A number of restriction-enzyme polymorphisms (RFLPs) have been
observed within this 35-kbp gene with eight exons, including polymorphisms
for TaqI (Camerino et al. 1984), XmnI and HinfIlDdeI (Winship et al. 1984),
MspIlHpaII (Camerino et al. 1985), and BamHI (Hay et al. 1986). They have
been used clinically with hemophilia B kindred for detecting carriers and af-
fected fetuses in utero (Camerino et al. 1983; Choo et al. 1984; Giannelli et al.
1984; Grunebaum et al. 1984; Hassan et al. 1985). The diagnostic value of the
polymorphisms depends in large part on the relative frequencies of the alleles at
the polymorphic sites, since heterozygosity of the mother for both hemophilia
B and an RFLP is the sine qua non. All earlier studies providing population
data have come from Europe or the United Kingdom and have, presumably,
been carried out on Caucasians. The allelic ratios have been in the range 65:35
-79:21, and it occurred to us that non-European populations might have quite
different gene frequencies.
We have obtained estimates of the frequencies of the polymorphic TaqI and
XmnI alleles in five ethnic groups: white Americans, black Americans, East
Indians, Chinese, and Malays. They vary greatly between the ethnic groups.
The allelic ratios and linkage disequilibria suggest that the polymorphisms may
be of limited diagnostic value for a large part of the world's population.
MATERIAL AND METHODS
Blood samples for DNA studies were obtained in one of two ways. The
American groups (white and black; female and male) consisted of sequential,
unrelated specimens received by the clinical laboratories of the North Carolina
Memorial Hospital for other purposes and destined to be discarded. They
arrived consecutively during a period of several months during the winter and
spring of 1985. All samples were <10 ml, and, since DNA was sparse in some
instances, only one polymorphism was assessed in some individuals. The only
selection in the sampling process consisted of rejection of hemolyzed speci-
mens or tubes whose contents clearly appeared to be insufficient. DNA was
prepared from the cell mass by standard methods (Maniatis et al. 1982).
Blood samples for the three Oriental groups were obtained in Kuala Lumpur,
Malaysia, in February 1986 from subjects whose ancestry was regarded locally
as solely East Indian, Chinese, or Malay. The subjects were either students or
staff of the university and were unrelated as far as was known. One of us
(D.B.L.) supervised the preparation of cell pellets under sterile conditions from
-50 ml of blood mixed with 0.4 ml of 0.5 M potassium ethylenediamine-
tetraacetate. The anticoagulated samples remained at room temperature for
1-24 h before addition of sucrose-Triton buffer. Aliquots of 12.5 ml each were
diluted to 50 ml by addition of sucrose-Triton at 4 C, the final concentrations in
the mixtures being 0.32 M sucrose, 10mM Tris, 5 mM magnesium chloride, and
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1% Triton X-100 at pH 7.6. After 10 min incubation at 4 C, samples were spun
at 1,000 g at 4 C and the supernatants were decanted. The nuclear pellets were
frozen at - 70 C and stored until all had been collected. Pellets were transferred
to 2-ml tubes that were then filled with a mixture of saline (75 mM), potassium
ethylenediaminetetraacetate (24 mM at pH 8.0), 50 pug of proteinase K/ml, and
1% sodium dodecyl sulfate. The tightly capped tubes were transported to
the United States at room temperature over a several day period and frozen at
- 70 C on arrival. A tube was thawed at 37 C for 2 h, and DNA was prepared by
standard methods (Maniatis et al. 1982). Although the yields varied somewhat,
the quality of the DNA was excellent; it spooled well and cut cleanly with the
enzymes used; no unusual fragments of DNA were encountered. (More re-
cently, cell pellets have been prepared in Malmo, Sweden, by means of the
same protocol and shipped successfully to us by ordinary air mail.) All DNA
samples were examined by Southern blotting (Southern 1975). Filters were
probed for the DNA polymorphisms with pAla36, a genomic fragment from a
patient with F.IX Alabama, a point mutation (Davis et al. 1987). The probe is
the 2.444-kbp fragment of genomic DNA between the sixth HindI11 and
fourth EcoRL sites of genomic F.IX DNA (Yoshitake et al. 1985) and spans
exon D.
RESULTS
Genotypes and Gene Frequencies
A total of 509 chromosomes were assessed for TaqI, 472 for XmnI. The
genotypes observed in the five ethnic groups are displayed separately by sex
and polymorphism in table 1. The 1,1 and 1,2 genotypes are seen in the females
of all ethnic groups except the Malay, which contained no heterozygotes. With
TABLE 1
FREQUENCIES OF THE GENOTYPES OBSERVED IN THE FEMALES AND MALES OF FIVE ETHNIC
GROUPS FOR Two F.IX POLYMORPHISMS
FREQUENCY FOR POLYMORPHISM/GENOTYPE
GENDER AND ETHNIC GROUP TaqI XmnI
Females 1,1 1,2 2,2 1,1 1,2 2,2
White American .29 19 5 33 17 3
Black American .38 14 0 37 11 0
East Indian .21 5 0 23 3 0
Chinese .17 1 0 17 1 0
Malay .23 0 0 19 0 0
Males 1 2 1 2
White American .35 9 29 9
Black American .28 9 31 5
East Indian .26 2 26 2
Chinese .32 0 32 0
Malay ............................... 22 1 23 0
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one exception, no type 2 alleles were seen in Chinese or Malay males, and the
2,2 genotype was seen only in white Americans. In short, allele 1, the designa-
tion for the larger fragment that results from absence of the middle restriction-
enzyme recognition site, is more common than allele 2 for both polymorphisms
in all populations.
Gene frequencies of alleles 1 and 2 are displayed separately for each poly-
morphism and ethnic group in table 2. Since the frequencies within ethnic
groups were not significantly different between males and females, the data for
each ethnic group were combined. Also shown are the frequencies of heterozy-
gosity for each polymorphism in each ethnic type of female. Observed and
expected heterozygote frequencies varied only slightly.
Table 3 shows, pairwise, the statistical tests of significance for the differ-
ences in gene frequencies between ethnic groups. The first row shows that the
difference between white and black Americans is almost significant at the 5%
level for TaqI and that it is significant at 5% for XmnI. The second row shows
that the differences between white Americans and East Indians is highly
significant for both polymorphisms, while the third row shows that the differ-
ences between black Americans and East Indians are not significant.
For Europe and the British Isles, gene frequencies have been published for
both TaqI and XmnI. The mean allelic ratio was 66:34 for TaqI, based on the
263 chromosomes of four studies (Camerino et al. 1984; Choo et al. 1984;
Giannelli et al. 1984; Hassan et al. 1985), while Winship et al. (1984) found a
ratio of 71:29 for XmnI in a sample of 72 chromosomes. Rows four and five of
table 3 show comparisons of European frequencies with those of white and
black Americans. The white American-European difference is almost signifi-
cant for TaqI but not for XmnI, while the black American-European differ-
ences are highly significant for both polymorphisms. (The latter result was
similar for Europeans and white Americans vs. East Indians, Chinese, and
Malays.)
It has been hypothesized that -20% of the genes of black Americans
originated from matings with white Americans (Reed 1969). When this estimate
is used together with the American data, it is possible to estimate the average
frequency of the rarer TaqI and XmnI alleles in the parts of Africa from which
black slaves were exported to America: let X be the African frequency sought;
.8 = the proportion of African genes in American blacks; .2 = the proportion
of white-American genes in American blacks; a = observed frequency of a
polymorphism in American whites; and b = observed frequency of a polymor-
phism in American blacks. Then, 0.8 (X) + 0.2 (a) = b. X for TaqI in Africans
= 0.138,andXforXmnlinAfricans = 0.095.
Heterozygote Frequencies
The probability of encountering a female of an ethnic group who is heterozy-
gous for either one or both of the polymorphisms can be calculated from the
gene frequencies. The calculation assumes that the polymorphisms are distrib-
uted randomly with respect to the gene frequencies. The results are displayed
in the first column of table 4, the expected frequencies being greatest in white












0 " O 00O0









































































































DIFFERENCES OF GENE FREQUENCIES BETWEEN ETHNIC GROUPS
DIFFERENCES
TaqI Polymorphism XmnI Polymorphism
COMPARISONS X2 P X2 P
White American vs.
black American ......... 3.68 .10 > .05 4.89 <.05
White American vs.
East Indian ............. 9.12 <.005 9.11 <.005
Black American vs.
East Indian ............. 2.42 >.10 1.81 >.10
European vs.
white American ......... 3.25 .10 > .05 1.25 >.20
European vs.
black American ......... 21.24 <.0001 9.11 <.0001
Americans and least in Malays. The second column shows that the observed
order parallels the expected order but is less than expected in each instance.
Column three shows that observed values ranged from 71% to 27% of expected
values, the difference being due to linkage disequilibrium.
Linkage Disequilibrium and the Haplotypes
The haplotypes for two diallelic genes that are linked are the four combina-
tions in which they may occur on a single chromosome. Since the exact hap-
lotypes of double heterozygotes cannot be determined without family studies
yet comprised a large part of our data, we devised the following scheme to
utilize them. The number of doubly heterozygous chromosomes in each ethnic
group was multiplied by the probability of the occurrence of each haplotype
(from the gene frequencies), and each result was converted to the nearest
integer. There were 12 white-American, 10 black-American, 3 East-Indian, 1
Chinese, and 0 Malay double heterozygotes who were haplotyped by this
method. The method is conservative, since it will tend to underestimate slightly
TABLE 4
FREQUENCY OF HETEROZYGOSITY FOR EITHER ONE OR BOTH POLYMORPHISMS
Ethnic Group (N) Expected Observed Observed/Expected
White American (39) ......... .607 .436 (17/39) .71
Black American (36) ......... .401 .278 (10/36) .69
East Indian (26) ............. .269 .192 (5/26) .71
Chinese (17) ................. .219 .060 (1/17) .27
Malay (19) .................. .000 .000 (0/19) .00
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TABLE 5
HAPLOTYPES FOR Two F.IX POLYMORPHISMS
TaqI
HAPLOTYPES XmnI
1 2 1 2 NO OF.
ETHNIC GROUP (N) 1 1 2 2 CHROMOSOMES X2 P D
White American:
Males (38) .... 25 4 5 4 38
Females (52) .. 75 13 6 10 104
Total (90) ... 100 17 11 14 142 20.76 <.0001 .0602
Black American:
Males (36) .... 26 5 0 5 36
Females (43) .. 78 6 2 0 86
Total (79) ... 104 11 2 5 122 ... .000364a .0199
East Indian:
Males (28) .... 26 0 0 2 28
Females (26) ... 49 2 1 0 52
Total (54) ... 75 2 1 2 80 ... .0056a .0220
Chinese:
Males (32) .... 32 0 0 0 32
Females (18) .. 34 1 1 0 36
Total (50) ... 66 1 1 0 68 ... ... ...
Malay:
Males (23) .... 22 1 0 0 23
Females (19) .. 38 0 0 0 38
Total (42) ... 60 1 0 0 61 ... ... ...
a By Fisher's exact method.
the true value of the disequilibrium. The scheme was used only for the females,
since the haplotype is identical with the genotype in males.
Table 5 shows the haplotypes for the TaqI and XmnI polymorphisms, both
separately by sex and combined, for each of the five ethnic groups. When
possible, statistical tests were performed on the combined data for each group,
i.e., X2-test on the white-American data and Fisher's exact test on the black-
American and East-Indian data. The Chinese and Malay data were not tested
because of the absence of one or more haplotypes. The large X2-value for white
Americans and the very small probability imply that linkage disequilibrium
exists (Ott 1985, p. 151 ff.). Exact probabilities calculated for black Americans
and East Indians are of the same order and have the same implication. The
parameter D, a measure of disequilibrium obtained from the haplotype frequen-
cies as the difference between cross-products in a 2 x 2 matrix (Ott 1985, p.
151 ff.), was greatest in white Americans and much lower in black Americans
and East Indians. It has no meaning in Chinese and Malays, in whom there
appears to be fixation of type 1 alleles.
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DISCUSSION
The TaqI polymorphism was first described by Camerino et al. (1984), the
XmnI polymorphism by Winship et al. (1984). They are present in the 5' half of
the FIX gene, the polymorphic sites being -3.8 kbp apart. Because of their
proximity, the polymorphisms are expected to be in strong linkage disequilib-
rium (Graham et al. 1985). Our data show this particularly well in white Ameri-
cans, but in all groups there is an obviously strong association between the type
1 allele of TaqI and the type 1 allele of XmnI. The predominance of type 1
alleles means that absence of the middle recognition site is much more common
than its presence. Our data show that the association between type 1 alleles is
greatest in Africans and Orientals. Since Africa and China are considered the
likeliest sites of origin(s) of Homo sapiens, absence of the middle sites may
have been the original condition in humans. Polymorphism at the middle sites
may have resulted more recently from mutations-perhaps in Europe, from
where they then spread outward. It will be of interest to see whether any well-
defined European population has particularly high frequencies of the rarer type
2 alleles.
The reduction in heterozygosity of the polymorphisms that were due to
linkage disequilibrium averaged -28%-30% in white and black Americans and
East Indians and was essentially absent in Chinese and Malays. This means
that clinical studies in Africa and the Orient will depend on the discovery and
study of other polymorphisms. The most valuable polymorphisms for use in all
groups might be those located at some distance from the region containing the
polymorphic TaqI and XmnI sites. Perhaps, in a variety of ethnic groups, the
BamHI polymorphism near exon I (Hay et al. 1986) should be explored with
this in mind. Special attention might also be given to the 3' end of the gene and
the 5' flanking DNA, since most of the polymorphisms reported to date have
been in the gene's midportion.
The frequency of the rarer TaqI allele is higher in Europeans (reported by
others) than in our group of white Americans. This is somewhat of a surprise,
since the ancestors of the white Americans in the North Carolina sample came
overwhelmingly from Scotland, Wales, Ireland, and northern England. This
suggests that significant genetic drift may have occurred since the American
migrations from Britain began in earnest about 1700. More striking are the
lower values in black Americans than in white Americans and, especially,
Europeans. When the black-American frequencies are adjusted for white-
American admixture, values for the rarer alleles that might tentatively be re-
garded as truly African-i.e., .138 for TaqI and .095 forXmnI-are fairly close
to those for East Indians-.09 and .06, respectively. Perhaps the African:East
Indian convergence is an expression of genetic similarity resulting from gene
flow over the land bridge connecting Asia and Africa and around the edges of
the rather small ocean that separates the Indian subcontinent from Africa.
Our results show very clearly that the frequencies of these two FIX DNA
polymorphisms vary greatly with ethnicity and that local frequencies are an
important consideration when a laboratory is selecting polymorphisms for diag-
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nostic purposes. The low frequency of the type 2 alleles in African and Oriental
populations means that the TaqI and XmnI polymorphisms will have little
diagnostic utility in large areas of the world.
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